Lantheus Holdings Priced, Nasdaq: LNTH

Sells medical imaging agents used in the diagnosis of cardiovascular diseases.

Industry: Health Care

Latest Trade: $17.25 0.00 (0.0%)

First Day Return: +12.8%

Return from IPO: +187.5%

Industry: Health Care

We are a global leader in developing, manufacturing, selling and distributing innovative diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases. Our agents are routinely used to diagnose coronary artery disease, congestive heart failure, stroke, peripheral vascular disease and other diseases. Clinicians use our imaging agents and products across a range of imaging modalities, including echocardiography, nuclear imaging and MRI. We believe that the resulting improved diagnostic information enables healthcare providers to better detect and characterize, or rule out, disease, potentially achieving improved patient outcomes, reducing patient risk and limiting overall costs for payers and the entire healthcare system.
more less
IPO News for Lantheus Holdings
more
IPO Data
IPO File Date 06/24/2014
Offer Price $6.00
Price Range $8.50 - $10.50
Offer Shares (mm) 10.8
Deal Size ($mm) $65
IPO Data
IPO Date 06/24/2015
Offer Price $6.00
Price Range $8.50 - $10.50
Offer Shares (mm) 10.8
Deal Size ($mm) $65
Underwriters
more
Company Data
Headquarters North Billerica, MA
Founded 1956
Employees 521
Website www.lantheus.com